SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Advanced Life Sciences Holdings, Inc. (CIK 0001322734) — Jul 28, 2005

Advanced Life Sciences Holdings, Inc. (CIK 0001322734)
Date: July 28, 2005 · CIK: 0001322734 · Accession: 0001047469-05-020250

AI Filing Summary & Sentiment

File numbers found in text: 333-124396

Date
July 28, 2005
Author
submitted
Form
CORRESP
Company
Advanced Life Sciences Holdings, Inc. (CIK 0001322734)

Letter

Division of Corporate Finance Securities and Exchange Commission Washington, D.C. 20549 Re:Advanced Life Sciences Holdings, Inc. ("ALS") Registration Statement on Form S-1 File No. 333-124396

Dear Mr. Riedler:

On behalf of ALS and pursuant to Rule 461 under the Securities Act of 1933, as amended, we hereby respectfully request that the Securities and Exchange Commission take such action as may be necessary and proper in order that the above-referenced Registration Statement be declared effective at 5:30 p.m. (Washington D.C. time), on Thursday, July 28, 2005, or as soon thereafter as practicable.

On behalf of ALS, we further acknowledge that:

•should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

•the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve ALS from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

•ALS may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Please call me at (312) 558-5609 to provide notice of the effectiveness of the Registration Statement.

Respectfully
submitted,
/s/
R. Cabell Morris, Jr.

Show Raw Text
CORRESP
1
filename1.htm

[Letterhead of Winston & Strawn LLP]

July 28, 2005

Jeffrey
P. Riedler

Assistant Director

Division of Corporate Finance

Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, D.C. 20549

Re:Advanced Life Sciences Holdings, Inc. ("ALS")

Registration Statement on Form S-1

File No. 333-124396

Dear Mr. Riedler:

        On
behalf of ALS and pursuant to Rule 461 under the Securities Act of 1933, as amended, we hereby respectfully request that the Securities and Exchange Commission take such action
as may be necessary and proper in order that the above-referenced Registration Statement be declared effective at 5:30 p.m. (Washington D.C. time), on Thursday, July 28, 2005, or
as soon thereafter as practicable.

        On
behalf of ALS, we further acknowledge that:

•should
the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with
respect to the filing;

•the
action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve ALS from its full responsibility for
the adequacy and accuracy of the disclosure in the filing; and

•ALS
may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

        Please
call me at (312) 558-5609 to provide notice of the effectiveness of the Registration Statement.

Respectfully
submitted,

/s/
R. Cabell Morris, Jr.

R.
Cabell Morris, Jr.